BD PureHub disinfecting cap

Risk reduction is at your fingertips1

BD PureHub disinfecting cap is used as a disinfecting device for swabbable needle-free luer connectors prior to access, and acts as a physical barrier between line accesses. The BD PureHub disinfecting cap provides rapid disinfection in just one minute, maintains a physical barrier for up to seven days, is compatible with needle-free luer connectors and supports compliance with disinfection protocols to deliver optimal patient outcomes.2,3

Minimize risk. Maximize outcomes

Non-adherence to aseptic technique, such as hub disinfection, is a major risk factor for development of catheter-related bloodstream infection (CRBSI).4

Support optimal outcomes

Disinfecting cap use can result in cost savings, fewer infections and deaths, and more free beds and working days.4,5‡

Reduce the risk of CLABSI

In clinical studies, disinfecting caps reduced the risk of central-line associated bloodstream infection (CLABSI) by 41%.3*† 

Supported by guidelines

Disinfecting cap use is supported by the Infusion Nursing Society (INS) Standards of Practise 2016,6 and several other international guidelines.

Rapid, powerful disinfection

Sterilised 70% isopropyl alcohol solution provides a >4 log (99.99%) reduction in bacteria in just 1 minute.2,§


Maintains a physical barrier against contamination for up to seven days, and provides confirmation of compliance with disinfection protocol.2,4

Ease of use

Shown to be compatible with needle-free luer connectors, with large width and finger grips for ease of application and removal.2

Optimal outcomes

The integrated offering of BD Vascular Access Management, in line with clinical guidance, can reduce complications and deliver optimal patient outcomes.

Visit online catalogue

In our online catalogue, you can easily view or request a quote for our:

View full catalogue »

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.


* Incidence Rate Reduction = 0.59, 95% CI = 0.45–0.77, p < 0.001; per 1,000 catheter-days.

† Compared to traditional needle-free connector disinfection.

‡ Per year, based on an 8-hour day; compared to traditional needle-free connector disinfection; based on a cost per CRBSI of $45,000.

§ Demonstrated reduction on the most common causative agents of CRBSI including Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Candida glabrata and Candida albicans

  1. Sweet MA, Cumpston A, Briggs F, Craig M, Hamadani M. Impact of alcohol-impregnated port protectors and needleless neutral pressure connectors on central line-associated bloodstream infections and contamination of blood cultures in an inpatient oncology unit. Am J Infect Control. 2012;40(10):931-934.
  2. Data on file, BD 1,2,3,4,5.
  3. Voor In ’t Holt AF, Helder OK, Vos MC, et al. Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: A systematic review and meta-analysis. Int J Nurs Stud. 2017;69:34-40.
  4. Cameron-Watson C. Port protectors in clinical practise: an audit. Br J Nurs. 2016;25(8):S25-31.
  5. Stango C, Runyan D, Stern J, Macri I, Vacca M. A successful approach to reducing bloodstream infections based on a disinfection device for intravenous needleless connector hubs. J Infus Nurs. 2014;37(6):462-465.
  6. Gorski LA, Hadaway L, Hagle ME, McGoldrick M, Orr M, Doellman D. Infusion therapy standards of practice.J Infus Nurs. 2016;39(Suppl 1):S1-S159.

This site uses cookies. If you click accept cookies then all cookies will be written. Please review our cookies policy and configure your cookies for your experience.